Century Therapeutics (IPSC)
NASDAQ:IPSC
US Market
Holding IPSC?
Track your performance easily

Century Therapeutics (IPSC) Ownership - Who Owns Century Therapeutics?

143 Followers

Century Therapeutics (IPSC) Ownership Overview

3.69%5.31%0.06%5.18%85.76%
0.06% Other Institutional Investors
5.18% ETFs
85.76% Public Companies and
Individual Investors
The ownership structure of Century Therapeutics (IPSC) stock is a mix of institutional, retail, and individual investors. Approximately 10.55% of the company’s stock is owned by Institutional Investors, 3.69% is owned by Insiders, and 85.76% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 05, 2024
xxxxxxxxxxxxx
$1260
Nov 05, 2024
Douglas Carr
Svp Finance & Operations
xxxxxxxxxxxxx
$21275
Sep 16, 2024
Daphne Quimi
Director
xxxxxxxxxxxxx
$7650
Aug 07, 2024
xxxxxxxxxxxxx
$1953

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,444,605Institution2.88%3,520,231
1,638,509Institution1.93%2,359,453
1,470,704Insider1.73%2,117,814
1,413,995Institution1.66%2,036,153
1,285,970Institution1.51%1,851,797
797,460Institution0.94%1,148,342
560,544Insider0.66%807,183
507,403Institution0.60%730,660
418,326Institution0.49%602,389
367,706Insider0.43%529,497

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,413,995Institution1.66%2,036,153
1,285,970Institution1.51%1,851,797
507,403Institution0.60%730,660
418,326Institution0.49%602,389
218,004Institution0.26%313,926
152,359Institution0.18%219,397
143,800Institution0.17%207,072
142,853Institution0.17%205,708
69,955Institution0.08%100,735
25,978Institution0.03%37,408

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,314,621Institution1.55%2,248,002
1,085,388Institution1.28%1,562,959
785,571Institution0.92%1,343,326
423,504Institution0.50%609,846
210,744Institution0.25%360,372
167,997Institution0.20%245,276
100,006Institution0.12%171,010
110,391Institution0.13%158,963
44,852Institution0.05%65,484
31,732Institution0.04%54,262

FAQ

Who Owns Century Therapeutics (IPSC)?
According to the latest TipRanks data, approximately 0.06% of the company's stock is held by institutional investors, 3.69% is held by insiders, and 85.76% is held by retail investors.
    What percentage of Century Therapeutics (IPSC) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.06% of Century Therapeutics (IPSC) stock is held by institutional investors.
      What percentage of Century Therapeutics (IPSC) stock is held by retail investors?
      According to the latest TipRanks data, approximately 85.76% of Century Therapeutics (IPSC) stock is held by retail investors.
        Who owns the most shares of Century Therapeutics (IPSC)?
        Vanguard owns the most shares of Century Therapeutics (IPSC).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis